DTIL Precision BioSciences, Inc.
$7.17▼ -0.97%
Healthcare
Other
After hours
$7.17▲ +0.00%
Sep 11, 7:30 PM ET
Volume 191.4K
Avg Volume (10D) 211.0K
Key Metrics & Fundamentals
Market Cap
$197.90M
P/E Ratio
–
Div Yield
–%
52W Range
3.53 - 9.62
% vs 50 MA
-8.34%
% vs 200 MA
15.64%
RSI-14
37.7
MACD Histogram
-0.1100
Beta (1Y vs SPY)
1.02
Free Cash Flow
-$13.44M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$17.62M
COGS
–
Operating Exp
$19.16M
Operating Income
-$19.16M
EBIT
-$19.16M
Pretax Income
-$32.65M
Net Income
-$32.65M
EPS (Diluted)
-1.26
Price & Volume History
Loading chart…
Recent News
Precision BioSciences Doses First Patient in Trial of Potential Duchenne Muscular Dystrophy Treatment
MT Newswires · Aug 24, 2026 10:46 AM
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
Business Wire · Aug 24, 2026 10:01 AM
Precision BioSciences: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 11:24 AM
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Wire · Aug 6, 2026 11:01 AM
Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026
Business Wire · Jul 31, 2026 11:01 AM
Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones
Business Wire · Jul 27, 2026 11:01 AM
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Jul 10, 2026 11:01 AM
Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?
Zacks · Jul 8, 2026 2:32 PM
Precision BioSciences Joins Russell 2000 Index
MT Newswires · Jun 29, 2026 6:44 PM
Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors
Business Wire · Jun 29, 2026 11:01 AM
Financial Overview - Income Statement
Quarterly
Mar 2026
See DTIL's money flow as a full page
Social Sentiment
No Reddit posts found for DTIL.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.